Can a short, early blitz of powerful drugs stop arthritis for good?

NCT ID NCT04435288

Ongoing Disease control Sponsor: University Hospital, Ghent Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 08, 2026 · Updated 20 times

Summary

This study is testing if starting with a powerful arthritis drug right away is better than the standard step-by-step approach for people newly diagnosed with a type of inflammatory joint disease. It aims to see if this early, intensive treatment can put the disease into remission, allowing patients to stop all medication for a long time. The trial will also check if this strategy works better for people treated within the first 3 months of symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL SPONDYLOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

ASZ Aalst

Aalst, 9300, Belgium
AZ Maria Middelares

Ghent, 9000, Belgium
AZ Sint-Jan

Bruges, 8000, Belgium
UZ Ghent

Ghent, 9000, Belgium
UZ Leuven Gasthuisberg

Leuven, 3000, Belgium
ZNA Jan Palfijn

Merksem, 2170, Belgium

Conditions

Explore the condition pages connected to this study.

PERIPHERAL SPONDYLOARTHRITIS